Dyes for Your Near-Infrared Imaging Needs

table

IRDye® 800CW EGF Optical Probe

Why Target EGFR
IRDye® 800CW EGF Optical Probe is a near-infrared (NIR) labeled recombinant human epidermal growth factor (EGF). Epidermal growth factor receptor (EGFR) is one of a family of receptor tyrosine kinases found on the surface of epithelial cells, to which EGF binds. Many types of cancer cells have abnormally high EGFR levels on the cell surface (Table 1). In vivo assays of EGF binding have proven effective in monitoring specific solid tumor models that exhibit over-expression of EGFR2-6. EGF conjugated to LI-COR's IRDye 800CW NIR fluorophore provides a versatile probe that can be used for in vitro and in vivo assays, as well as whole organ and tissue section analysis.

Ordering Information

Please see our new Online Catalog for the latest ordering information.

For research purposes only. Not for diagnostic or therapeutic use. Not for use in humans. LI-COR IRDye 800 and other LI-COR reagent products are covered by U.S. patents, foreign equivalents, and patents pending.

Shipping information:
U.S.A.: Same-day shipping (Federal Express overnight) available on orders received before 12:00 noon CST.
Canada: Contact Mandel Scientific.
Germany & UK: Contact LI-COR GmbH.
International: Contact a LI-COR distributor in your area All shipments subject to availability.

IRDye is a registered trademark of LI-COR Inc.

Advantages of BrightSite™ Optical Agents

  • High signal-to-noise ratio.
  • Low NIR autofluorescence from tissues, cells, biological materials, and drug compounds.
  • IRDye 800CW absorption/emission near 800 nm matches NIR absorption minima for bodily fluids and tissues, resulting in excellent tissue penetration.

Molar extinction coefficient characteristics of water, hemoglobin and oxygenated hemoglobin (400-1000 nm). IRDye® infrared dyes have ideal excitation/emission wavelengths for in vivo imaging.

IRDye® 800CW EGF Optical Probe is composed of recombinant a EGF polypeptide containing 54 amino acid residues (molecular weight=6.2 kDa) conjugated to the LI-COR IRDye 800CW NIR fluorophore. IRDye® 800CW EGF has been optimized for research pertaining to tumor biology

graph

Probe Specificity
In-Cell Western assays on the LI-COR Odyssey® and Aerius® Infrared Imaging Systems are used to determine binding specificity of the probe in vitro for various cell lines (Figure 1). IRDye 800CW EGF has been characterized in A431 (squamous epithelial carcinoma, Figure 2), and PC3M-LN4 and 22Rv1 (human prostate adenocarcinoma) cell lines that over-express EGFR.

fig1

Figure 1 - Two different cell lines known to over-express the EGFR were characterized by evaluating:

    1. binding of IRDye 800CW EGF;
    2. IRDye 800CW only;
    3. competition assay using unlabeled EGF to compete for EGFR sites
fig2

Figure 2 - Two Athymic Nu/Nu tumor-bearing mice were injected with either 0.9% saline (left) or 1 nmol IRDye 800CW EGF (right) 72 hours prior to imaging with the LI-COR Odyssey Infrared Imaging System

 

Visit us on You TubeLike us on Facebook!Follow us on TwitterRed the blogger blog

Biotechnology
4647 Superior St Lincoln, NE 68504
Toll-Free: 800-645-4267
Email: biohelp@licor.com
Environmental
4421 Superior Street Lincoln, NE 68504
Toll-Free: 800-447-3576
Email: envsales@licor.com
© 2011 LI-COR Biosciences